Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Routine Pre-Apheresis Markers As Predictors for Efficacy and Safety Outcomes Following CD19 CAR-T Cell Therapy - a Single Center Experience

Blood (2024) 144 (Supplement 1): 6548.

https://doi.org/10.1182/blood-2024-205736

Published: 2024

Journal Articles

Clocking the Processes and Challenges of Urgent Red Blood Cell Exchange for Acute Complications of Sickle Cell Disease

Kristine Matusiak, Christine M. Cserti-Gazdewich, Nadine Shehata, Kevin H.M. Kuo, Justin Kim, David Barth, Christopher J. Patriquin

Blood (2023) 142 (Supplement 1): 2308.

https://doi.org/10.1182/blood-2023-184941

Published: 2023

Journal Articles

Single Centre, Retrospective Analysis of Extracorporeal Photopheresis (ECP) Therapy in the Patients Who Are Heavily Pre-Treated for Steroid Resistant Chronic Graft-Versus-Host Disease (GVHD)

Swe Mar Linn, Igor Novitzky-Basso, Christopher J. Patriquin, Ivan Pasic, Wilson Lam, Arjun Law, Fotios Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey H. Lipton, Rajat Kumar, Jonas Mattsson, David Barth, Dennis Dong Hwan Kim, Sr.

Blood (2021) 138 (Supplement 1): 1806.

https://doi.org/10.1182/blood-2021-152640

Published: 2021

Journal Articles

Propensity Score Matching Analysis Comparing Extracorporeal Photopheresis (ECP) Vs Best Available Therapy in Third Line or Later Treatment of Chronic Graft-Versus-Host Disease (cGVHD)

Swe Mar Linn, Igor Novitzky-Basso, Elizabeth Shin, Christopher J. Patriquin, Ivan Pasic, Wilson Lam, Arjun Law, Fotios Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey H. Lipton, Rajat Kumar, Jonas Mattsson, David Barth, Dennis Dong Hwan Kim, Sr.

Blood (2021) 138 (Supplement 1): 3896.

https://doi.org/10.1182/blood-2021-153045

Published: 2021

Journal Articles

Characterizing the Process of Urgent Referrals and Transfers to a Large Tertiary Care Apheresis Centre in Ontario

Kristine Matusiak, MD, Kevin H.M. Kuo, MDMSc,FRCPC, Andrew Binding, MD MSc, FRCPC, David Barth, MD FRCPC, Christopher J. Patriquin, MDMSc, FRCPC

Blood (2020) 136 (Supplement 1): 28.

https://doi.org/10.1182/blood-2020-136784

Published: 2020

Journal Articles

Rate of Sickle Hemoglobin Recovery in Sickle Cell Disease Patients Undergoing Red Blood Cell (RBC) Exchange Transfusion Is Associated with Age of Patients and Number of RBC Units Transfused

John Chinawaeze Aneke, MBBS, Aliraza Rajabali, Nafanta Fadiga, Stéphanie Forté, MD MSc, FRCPC, George A. Tomlinson, PhD BSc, MSc, Christine M. Cserti-Gazdewich, BSc, MD FRCPC, Christopher J. Patriquin, MDFRCPC,MSc, Richard Ward, MSc, MRCP, FRCPath, Jacob Pendergrast, MDFRCPC, David Barth, MD FRCPC, Kevin H. M. Kuo, MDMSc,FRCPC

Blood (2019) 134 (Supplement_1): 2170.

https://doi.org/10.1182/blood-2019-122072

Published: 2019

Journal Articles

S100B Is a Useful Marker for the Diagnosis of Haemophagocytic Lymphohistiocytosis

Rosemarie Tremblay-Lemay, MD MSc, FRCPC, Lourdes Calvente, MD, Monali Gupta, MD, Anne Tierens, MD PhD, David Barth, MD, John Kuruvilla, MD, Jan M.A. Delabie, MD PhD

Blood (2018) 132 (Supplement 1): 3711.

https://doi.org/10.1182/blood-2018-99-116783

Published: 2018

Journal Articles

Absence of Viral Complications When Using Rituximab to Treat TTP with Plasma Exchange

Gail Rock, PhD MD, Steven Weger, MD, Hana Abouhadjar, MD, David Barth, MD FRCPC, William Clark, MD, Paul R. Yenson, MD FRCPC, Stephen Ronan Foley, MD FRCPC

Blood (2015) 126 (23): 2261.

https://doi.org/10.1182/blood.V126.23.2261.2261

Published: 2015

Journal Articles

A Phase II Study Evaluating the Efficacy of Rituximab in the Management of Patients with Relapsed or Refractory TTP

Stephen Ronan Foley, MD FRCPC, Gail Rock, PhD MD, David Barth, MD FRCPC, Donald M. Arnold, MD MSc, Kathryn E Webert, MD FRCP(C), Paul R. Yenson, MD FRCPC, John G. Kelton, MD FRCPC, William Foster Clark, MD, Lihua Li

Blood (2014) 124 (21): 4191.

https://doi.org/10.1182/blood.V124.21.4191.4191

Published: 2014

Journal Articles

Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm By Using 10-Colour Flow Cytometry and Achievement of Remission By Hypercvad Therapy

Uday Deotare, MD DM, Elizabeth Hyjek, MD PhD, Anna Porwit, MDPhD, Rumina Musani, MDFCAP, FRCPC, David Barth, MD FRCPC, Emina Torlakovic, MD, Anne Tierens, MD PhD, Aaron D Schimmer, MDPhD, Andre C Schuh, MD FRCPC, Mark D. Minden, MD PhD, Vikas Gupta, MD FRCP, FRCPath, Matthew D. Seftel, MRCP, FRCPC, MPH, Naheed Alam, MBBS,MD, Karen W.L. Yee, MDFRCPC

Blood (2014) 124 (21): 2365.

https://doi.org/10.1182/blood.V124.21.2365.2365

Published: 2014

Journal Articles

A Comparison of Automated Red Blood Cell Depletion/Exchange to Automated Red Cell Blood Exchange in Sickle Cell Patients.

Kevin H.M. Kuo, MD, FRCPC, David Barth, MD, FRCPC

Blood (2012) 120 (21): 2281.

https://doi.org/10.1182/blood.V120.21.2281.2281

Published: 2012

Journal Articles

Effectiveness, Time Utilization and Clinical Outcome of Partial Manual Red Cell Exchange in Patients with Sickle Cell Disease

Kevin H.M. Kuo, MD, David Barth, MD, Richard Ward, MD

Blood (2011) 118 (21): 2326.

https://doi.org/10.1182/blood.V118.21.2326.2326

Published: 2011

Journal Articles

Characteristics of Patients Presenting with Secondary Myelodysplastic Syndrome During Treatment with Lenalidomide for Relapsed/Refractory Multiple Myeloma: 5q Deletions Can Be Observed

Rashmi S. Goswami, BSc, MD, FRCPC, David Barth, MD, Esther Masih-Khan, PhD, Haowei (Linda) Sun, MD, Manoj Mathew, Christine Chen, MD, Suzanne Trudel, MD, MSC, FRCPC, Suzanne Kamel-Reid, Ph.D., Donna E. Reece, MD

Blood (2010) 116 (21): 1876.

https://doi.org/10.1182/blood.V116.21.1876.1876

Published: 2010

Journal Articles

Incidence and Characteristics of Secondary Myelodysplastic Syndrome Developing During Lenalidomide-Based Regimens In Relapsed and/or Refractory Multiple Myeloma Patients

Donna E. Reece, MD, Esther Masih-Khan, PhD, Rashmi S. Goswami, BSc, MD, FRCPC, Sharon Fung, David Barth, MD, Christine Chen, MD, Vishal Kukreti, MD, FRCPC, Haowei (Linda) Sun, MD, Saima Dean, Suzanne Trudel, MD, MSC, FRCPC

Blood (2010) 116 (21): 1877.

https://doi.org/10.1182/blood.V116.21.1877.1877

Published: 2010

Journal Articles

Prospective Evaluation of An Argatroban Dosing Nomogram Using the Ecarin Chromogenic Assay at a Tertiary Institution

Cathryn Sibbald, BScPhm, Jin-Hyeun Huh, BScPhm, ACPR, BCPS, William Brien, MD, FRCPC, Bassem Hamandi, BSc, BScPhm, MSc, Donna Lowe, BScPhm, PharmD, Menaka Pai, MD, Anne Mcleod, MD, FRCPC, Gary Wong, BScPhm, Erik Yeo, MD, David Barth, MD, FRCPC

Blood (2008) 112 (11): 3016.

https://doi.org/10.1182/blood.V112.11.3016.3016

Published: 2008

Journal Articles

Sezary Syndrome and Combination Immunomodulatory Therapy: Improving Clinical Outcomes

Eugenia Piliotis, MD, Panayiota Govas, Kevin R Imrie, MD, Matthew C Cheung, MD, Neil Shear, Scott Walsh, MD, FRCPC, Cathy Fairlie, RN, David Barth, MD, FRCPC

Blood (2008) 112 (11): 4957.

https://doi.org/10.1182/blood.V112.11.4957.4957

Published: 2008

Journal Articles

ADAMTS-13 Levels Do Not Predict Outcome in Thrombotic Thrombocytopenic Purpura: Protein S Levels Are Maintained during Plasma Exchange with Solvent Detergent Treated Plasma.

Gail A. Rock, Phd, MD, FRCPC, David Anderson, MD, Barrett Benny, MD, David Barth, MD, William Clark, MD, Ronan Foley, MD, David Sutton, MD, Pierre Leblond, MD

Blood (2007) 110 (11): 2895.

https://doi.org/10.1182/blood.V110.11.2895.2895

Published: 2007

NARROW

Routine Pre-Apheresis Markers As Predictors for Efficacy and Safety Outcomes Following CD19 CAR-T Cell Therapy - a Single Center Experience

Clocking the Processes and Challenges of Urgent Red Blood Cell Exchange for Acute Complications of Sickle Cell Disease

Single Centre, Retrospective Analysis of Extracorporeal Photopheresis (ECP) Therapy in the Patients Who Are Heavily Pre-Treated for Steroid Resistant Chronic Graft-Versus-Host Disease (GVHD)

Propensity Score Matching Analysis Comparing Extracorporeal Photopheresis (ECP) Vs Best Available Therapy in Third Line or Later Treatment of Chronic Graft-Versus-Host Disease (cGVHD)

Characterizing the Process of Urgent Referrals and Transfers to a Large Tertiary Care Apheresis Centre in Ontario

Rate of Sickle Hemoglobin Recovery in Sickle Cell Disease Patients Undergoing Red Blood Cell (RBC) Exchange Transfusion Is Associated with Age of Patients and Number of RBC Units Transfused

S100B Is a Useful Marker for the Diagnosis of Haemophagocytic Lymphohistiocytosis

Absence of Viral Complications When Using Rituximab to Treat TTP with Plasma Exchange

A Phase II Study Evaluating the Efficacy of Rituximab in the Management of Patients with Relapsed or Refractory TTP

Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm By Using 10-Colour Flow Cytometry and Achievement of Remission By Hypercvad Therapy

A Comparison of Automated Red Blood Cell Depletion/Exchange to Automated Red Cell Blood Exchange in Sickle Cell Patients.

Effectiveness, Time Utilization and Clinical Outcome of Partial Manual Red Cell Exchange in Patients with Sickle Cell Disease

Characteristics of Patients Presenting with Secondary Myelodysplastic Syndrome During Treatment with Lenalidomide for Relapsed/Refractory Multiple Myeloma: 5q Deletions Can Be Observed

Incidence and Characteristics of Secondary Myelodysplastic Syndrome Developing During Lenalidomide-Based Regimens In Relapsed and/or Refractory Multiple Myeloma Patients

Prospective Evaluation of An Argatroban Dosing Nomogram Using the Ecarin Chromogenic Assay at a Tertiary Institution

Sezary Syndrome and Combination Immunomodulatory Therapy: Improving Clinical Outcomes

ADAMTS-13 Levels Do Not Predict Outcome in Thrombotic Thrombocytopenic Purpura: Protein S Levels Are Maintained during Plasma Exchange with Solvent Detergent Treated Plasma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only